Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP538488.RAbgVZ4QhCeJEnaZycyEA7PQM_nAywIBCpLnVQG_6PtoQ130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538488.RAbgVZ4QhCeJEnaZycyEA7PQM_nAywIBCpLnVQG_6PtoQ130_provenance.
• NP236420.RAewfQqhxXQw2IUqbHtGlSQAlOsgiHuf4ZnK32HMvuXvs130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236420.RAewfQqhxXQw2IUqbHtGlSQAlOsgiHuf4ZnK32HMvuXvs130_provenance.
• NP164382.RAvZCELlspyoGEiDSNfMl3kdQWzXnhYe5a6onJX13jhKE130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164382.RAvZCELlspyoGEiDSNfMl3kdQWzXnhYe5a6onJX13jhKE130_provenance.
• NP194817.RApOihW0PxFQHsmmEhNAn8mxX5DtroEd6AUeCURPhtSz4130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194817.RApOihW0PxFQHsmmEhNAn8mxX5DtroEd6AUeCURPhtSz4130_provenance.
• NP464025.RAhaOqM-kQ7BKRVnMMKYg4tJ66k6J64cARd-WCmzMrf3g130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464025.RAhaOqM-kQ7BKRVnMMKYg4tJ66k6J64cARd-WCmzMrf3g130_provenance.
• NP560825.RAosAZ-e1tBH3c-ToBckFkCSG-zwlAHUOF-5eFjb1kZiY130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560825.RAosAZ-e1tBH3c-ToBckFkCSG-zwlAHUOF-5eFjb1kZiY130_provenance.
• NP837688.RArlzcDGj4cYh6l6jWziTvrO-jOzitWtMmsAekddMdL9I130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP837688.RArlzcDGj4cYh6l6jWziTvrO-jOzitWtMmsAekddMdL9I130_provenance.
• NP446523.RA7xPcCUJKTbu33CjJY6iRtIXuhXFcVVZQeIC6CdO-Tio130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP446523.RA7xPcCUJKTbu33CjJY6iRtIXuhXFcVVZQeIC6CdO-Tio130_provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP333108.RAUT9iNrTaSAw2PyYlp8FBC1UJ1VN7fiIPgtGsA3VIlC0130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333108.RAUT9iNrTaSAw2PyYlp8FBC1UJ1VN7fiIPgtGsA3VIlC0130_provenance.
• NP396732.RARxU7rgIqFm0j7hwcpduoYP7PDwmvq9iaAZl1SI80-eU130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396732.RARxU7rgIqFm0j7hwcpduoYP7PDwmvq9iaAZl1SI80-eU130_provenance.
• NP396894.RAR8_HxmiHJrbMqEnYTohR62Mz03h2NDvfy7srGUelTJc130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396894.RAR8_HxmiHJrbMqEnYTohR62Mz03h2NDvfy7srGUelTJc130_provenance.
• NP396895.RAQgnLHhQ1oYQSQEGYHEDAYrPJV40t-L397jhmkuM6JFk130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396895.RAQgnLHhQ1oYQSQEGYHEDAYrPJV40t-L397jhmkuM6JFk130_provenance.
• NP815104.RAR4vmrn602habMrCe2UC5dYxRRFXJfPlcbmjJ_SkDQoU130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815104.RAR4vmrn602habMrCe2UC5dYxRRFXJfPlcbmjJ_SkDQoU130_provenance.
• NP973754.RAeLwgbIDyZs_AC2WcWjT9ihKvNFdH8c75YO9VBrHnXDg130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973754.RAeLwgbIDyZs_AC2WcWjT9ihKvNFdH8c75YO9VBrHnXDg130_provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP396970.RADwNBpw0rGNJ5CBgJHHHvjJRXE1O1gF7bZWkBQOQuVWM130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396970.RADwNBpw0rGNJ5CBgJHHHvjJRXE1O1gF7bZWkBQOQuVWM130_provenance.
• NP333324.RADmueN-KMivRl3VW3f4tQDGZHLDMHxS17b_cU2R8ohyk130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333324.RADmueN-KMivRl3VW3f4tQDGZHLDMHxS17b_cU2R8ohyk130_provenance.
• NP925181.RAXu_WaCBl7KcO2OxS2QcviNpcdjDzOgzbN3IwFHaNObw130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925181.RAXu_WaCBl7KcO2OxS2QcviNpcdjDzOgzbN3IwFHaNObw130_provenance.
• NP925186.RAXNaa46ruqXlvxnqzGj0NOl_viURrbYJPeAwyLW2Busw130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925186.RAXNaa46ruqXlvxnqzGj0NOl_viURrbYJPeAwyLW2Busw130_provenance.
• NP925190.RAbfGrMjkRkvBfYMzdZOxnLBcg0qBO7crQr4TB0X6AKcU130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925190.RAbfGrMjkRkvBfYMzdZOxnLBcg0qBO7crQr4TB0X6AKcU130_provenance.
• NP925192.RAcaEun1mk2PWkkZ2uUbFKgO6EWwPoB2R4groh5eJAlp4130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925192.RAcaEun1mk2PWkkZ2uUbFKgO6EWwPoB2R4groh5eJAlp4130_provenance.
• NP815142.RAAc4GKG3EjHCOcWoECFUvrbx3ZQYFwaMv_ibiI02fQXE130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815142.RAAc4GKG3EjHCOcWoECFUvrbx3ZQYFwaMv_ibiI02fQXE130_provenance.
• NP925176.RABHmT82k22dapf7m_OBhWyMZYmlndOvd3JgJvbx19J9Y130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925176.RABHmT82k22dapf7m_OBhWyMZYmlndOvd3JgJvbx19J9Y130_provenance.
• NP396734.RAjpFLCkIHx9pBxtjKQlXjIym_kU0f1-EMWeFpyzWHxHU130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396734.RAjpFLCkIHx9pBxtjKQlXjIym_kU0f1-EMWeFpyzWHxHU130_provenance.
• NP973550.RAiU8fynEyMZZPgcmEYAlhG-aNGeyo-SG4ogJNTXF0Lyw130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973550.RAiU8fynEyMZZPgcmEYAlhG-aNGeyo-SG4ogJNTXF0Lyw130_provenance.
• NP815105.RAmBHB0N5GJLOrRhzcv-cG9j4Ubl8MvZP3deJvH4l2Cq4130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815105.RAmBHB0N5GJLOrRhzcv-cG9j4Ubl8MvZP3deJvH4l2Cq4130_provenance.
• NP925184.RAmWaah3pvWuLf-dnxkzzhtbqV3EJ597LxzCqREDptSlo130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925184.RAmWaah3pvWuLf-dnxkzzhtbqV3EJ597LxzCqREDptSlo130_provenance.
• NP925187.RAnu8Qwy04eqEK3IeX7AIKyPCW0lrwbALFNEnmCjBrrxU130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925187.RAnu8Qwy04eqEK3IeX7AIKyPCW0lrwbALFNEnmCjBrrxU130_provenance.
• NP925191.RAuntFLEYz_8gnmTTf9UXTu6qAhINRNL0SB1SFXAgQ1u4130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925191.RAuntFLEYz_8gnmTTf9UXTu6qAhINRNL0SB1SFXAgQ1u4130_provenance.
• NP396861.RA1GEE5CoLo2a-VDfVJ7jBeDokK3VvJDvuiNkVd2KA5Eo130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396861.RA1GEE5CoLo2a-VDfVJ7jBeDokK3VvJDvuiNkVd2KA5Eo130_provenance.
• NP333117.RAKGj-qMnbBK0p1GdoJmhnDwehI0JoNRAv4lE48Sjpm6s130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333117.RAKGj-qMnbBK0p1GdoJmhnDwehI0JoNRAv4lE48Sjpm6s130_provenance.
• NP925177.RAKjVfF60tly_VsYM-USl9njQOiksntWpnMdBewjV1yYo130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925177.RAKjVfF60tly_VsYM-USl9njQOiksntWpnMdBewjV1yYo130_provenance.
• NP925178.RAMvjvOCscFaQagG5lck_fkKjDWioSX0SvSNuD0QzFsMU130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925178.RAMvjvOCscFaQagG5lck_fkKjDWioSX0SvSNuD0QzFsMU130_provenance.
• NP925182.RAFJ0TOoWG_HhCGd3DwpKARhIZGJgl0UwOtjOhHDQ4L8o130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925182.RAFJ0TOoWG_HhCGd3DwpKARhIZGJgl0UwOtjOhHDQ4L8o130_provenance.
• NP925189.RAFXVg-nfCADCcou_wSiTeWkHAVEpLV6Fh101mh_uRYz4130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925189.RAFXVg-nfCADCcou_wSiTeWkHAVEpLV6Fh101mh_uRYz4130_provenance.
• NP925193.RAFl6wdSe692cmm3PdUAmYoCAx3Pqrjcs73TTpzKTzPJ8130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925193.RAFl6wdSe692cmm3PdUAmYoCAx3Pqrjcs73TTpzKTzPJ8130_provenance.
• NP973541.RAxfLF2l4RsK14gr28yW3sQsLpxwBGAFkOzFUq9DER9I0130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973541.RAxfLF2l4RsK14gr28yW3sQsLpxwBGAFkOzFUq9DER9I0130_provenance.
• NP925179.RA5j-s5rxJIKx77J3vl9PJJr94A4nrcFfnTXhP4oJq44M130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925179.RA5j-s5rxJIKx77J3vl9PJJr94A4nrcFfnTXhP4oJq44M130_provenance.
• NP925180.RAwvSVu0zEezWLOOj6ZE52-wLoQMVqy_qzoCyqNPJIfcY130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925180.RAwvSVu0zEezWLOOj6ZE52-wLoQMVqy_qzoCyqNPJIfcY130_provenance.
• NP925183.RA2xyzDwUdX8i-bvs_WI1nBN7RjGe6ka1LL0dRSjX4Ojs130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925183.RA2xyzDwUdX8i-bvs_WI1nBN7RjGe6ka1LL0dRSjX4Ojs130_provenance.
• NP925185.RA17F04h5FKex2sAkCxO75BVDZCK5Ykbo7UtlsZi7mE5c130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925185.RA17F04h5FKex2sAkCxO75BVDZCK5Ykbo7UtlsZi7mE5c130_provenance.
• NP925188.RA5vXe7UYSpDgXGKL3w_lcS4Qhdix2xp5GYw3s5DJEBtg130_assertion description "[We identified amino acid residues involved in CRP peptide 201-206-Fc?RII (CD32) interactions, which mediate potent antineutrophil and antiplatelet adhesion actions, and these findings open up new perspectives for limiting inflammation and thrombosis underlying coronary artery disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925188.RA5vXe7UYSpDgXGKL3w_lcS4Qhdix2xp5GYw3s5DJEBtg130_provenance.